Similar articles

• Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.

  Russ MA, Prondzinsky R, Carter JM, Schlitt A, Ebelt H, Schmidt H, Lemm H, Heinroth K, Soeffker G, Winkler M, Werdan K, Buerke M. Russ MA, et al. Crit Care Med. 2009 Dec;37(12):3017-23. doi: 10.1097/CCM.0b013e3181b0314a. Crit Care Med. 2009. PMID: 19661807
• Importance of levosimendan on right ventricular function in patients with biventricular heart failure.

  Erdem A, Birhan Yilmaz M. Erdem A, et al. Crit Care Med. 2010 May;38(5):1389-90; author reply 1390-1. doi: 10.1097/CCM.0b013e3181d8a322. Crit Care Med. 2010. PMID: 20404640 No abstract available.
• Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.

  Beute J. Beute J. Crit Care Med. 2009 Sep;37(9):2678; author reply 2678-9. doi: 10.1097/CCM.0b013e3181aff568. Crit Care Med. 2009. PMID: 19687655 No abstract available.
• Rational therapeutic approach to cardiogenic shock.

  Wiener L. Wiener L. Cardiovasc Clin. 1974;6(2):223-37. Cardiovasc Clin. 1974. PMID: 4613459 Review. No abstract available.
• Pharmacologic support in cardiogenic shock.

  Rude RE. Rude RE. Adv Shock Res. 1983;10:35-49. Adv Shock Res. 1983. PMID: 6349299 Review.